PATIENT IMPACT STATEMENT
The coalition has prepared a Joint Patient Impact Statement for use in different countries to aid when advocating for the provision of anti-COVID-19 treatment and care for immunocompromised (IC) blood cancer patients.
International COVID-19 Blood Cancer Coalition (ICBCC)
PATIENT IMPACT STATEMENT AND RECOMMENDATIONS
Protecting immunocompromised blood cancer patients during the COVID-19 pandemic
Date of release: 21 February 2022 / last updated: 13 June 2022
The Statement has to date been endorsed by networks and national organisations of the global patient advocacy community as well as renowned medical societies and representatives from the global clinical community
(73 endorsers to date).
The statement is now available for you to use and share!